Cargando…
Using antibodies to control DNA-templated chemical reactions
DNA-templated synthesis takes advantage of the programmability of DNA-DNA interactions to accelerate chemical reactions under diluted conditions upon sequence-specific hybridization. While this strategy has proven advantageous for a variety of applications, including sensing and drug discovery, it h...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7721721/ https://www.ncbi.nlm.nih.gov/pubmed/33288745 http://dx.doi.org/10.1038/s41467-020-20024-3 |
_version_ | 1783620082527633408 |
---|---|
author | Baranda Pellejero, Lorena Mahdifar, Malihe Ercolani, Gianfranco Watson, Jonathan Brown, Tom Ricci, Francesco |
author_facet | Baranda Pellejero, Lorena Mahdifar, Malihe Ercolani, Gianfranco Watson, Jonathan Brown, Tom Ricci, Francesco |
author_sort | Baranda Pellejero, Lorena |
collection | PubMed |
description | DNA-templated synthesis takes advantage of the programmability of DNA-DNA interactions to accelerate chemical reactions under diluted conditions upon sequence-specific hybridization. While this strategy has proven advantageous for a variety of applications, including sensing and drug discovery, it has been so far limited to the use of nucleic acids as templating elements. Here, we report the rational design of DNA templated synthesis controlled by specific IgG antibodies. Our approach is based on the co-localization of reactants induced by the bivalent binding of a specific IgG antibody to two antigen-conjugated DNA templating strands that triggers a chemical reaction that would be otherwise too slow under diluted conditions. This strategy is versatile, orthogonal and adaptable to different IgG antibodies and can be employed to achieve the targeted synthesis of clinically-relevant molecules in the presence of specific IgG biomarker antibodies. |
format | Online Article Text |
id | pubmed-7721721 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-77217212020-12-11 Using antibodies to control DNA-templated chemical reactions Baranda Pellejero, Lorena Mahdifar, Malihe Ercolani, Gianfranco Watson, Jonathan Brown, Tom Ricci, Francesco Nat Commun Article DNA-templated synthesis takes advantage of the programmability of DNA-DNA interactions to accelerate chemical reactions under diluted conditions upon sequence-specific hybridization. While this strategy has proven advantageous for a variety of applications, including sensing and drug discovery, it has been so far limited to the use of nucleic acids as templating elements. Here, we report the rational design of DNA templated synthesis controlled by specific IgG antibodies. Our approach is based on the co-localization of reactants induced by the bivalent binding of a specific IgG antibody to two antigen-conjugated DNA templating strands that triggers a chemical reaction that would be otherwise too slow under diluted conditions. This strategy is versatile, orthogonal and adaptable to different IgG antibodies and can be employed to achieve the targeted synthesis of clinically-relevant molecules in the presence of specific IgG biomarker antibodies. Nature Publishing Group UK 2020-12-07 /pmc/articles/PMC7721721/ /pubmed/33288745 http://dx.doi.org/10.1038/s41467-020-20024-3 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Baranda Pellejero, Lorena Mahdifar, Malihe Ercolani, Gianfranco Watson, Jonathan Brown, Tom Ricci, Francesco Using antibodies to control DNA-templated chemical reactions |
title | Using antibodies to control DNA-templated chemical reactions |
title_full | Using antibodies to control DNA-templated chemical reactions |
title_fullStr | Using antibodies to control DNA-templated chemical reactions |
title_full_unstemmed | Using antibodies to control DNA-templated chemical reactions |
title_short | Using antibodies to control DNA-templated chemical reactions |
title_sort | using antibodies to control dna-templated chemical reactions |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7721721/ https://www.ncbi.nlm.nih.gov/pubmed/33288745 http://dx.doi.org/10.1038/s41467-020-20024-3 |
work_keys_str_mv | AT barandapellejerolorena usingantibodiestocontroldnatemplatedchemicalreactions AT mahdifarmalihe usingantibodiestocontroldnatemplatedchemicalreactions AT ercolanigianfranco usingantibodiestocontroldnatemplatedchemicalreactions AT watsonjonathan usingantibodiestocontroldnatemplatedchemicalreactions AT browntom usingantibodiestocontroldnatemplatedchemicalreactions AT riccifrancesco usingantibodiestocontroldnatemplatedchemicalreactions |